SURVIVAL TIME AFTER LAPAROSCOPIC GASTROSCOPIC SURGERY FOR STOMACH CANCER TREATMENT USING THE KAPLAN-MEIER METHOD AT PEOPLE'S HOSPITAL 115
Main Article Content
Abstract
Objective: To evaluate the postoperative survival outcomes of patients undergoing laparoscopic gastrectomy for gastric cancer using the Kaplan–Meier method at 115 People’s Hospital.
Subjects and Methods: This was a retrospective, descriptive case series study. All patients who underwent laparoscopic gastrectomy for gastric cancer at the Department of General Surgery, 115 People’s Hospital, from January 2020 to December 2024, were included Clinical data were collected from medical records. Overall survival (OS) and disease-free survival (DFS) were analyzed using the Kaplan–Meier method.
Results: A total of 144 patients underwent laparoscopic gastrectomy with D2 lymph node dissection for gastric cancer. The recurrence rate was 4.9%. The distant metastasis rate was 21.5%, including: 17 cases of peritoneal metastasis, 7 cases of hepatic metastasis, 2 cases of pulmonary metastasis, 1 case of distant lymph node metastasis, and 4 cases with multiple-organ metastases. According to Kaplan–Meier survival estimates, the mean overall survival (OS) was 60.1 months (95% confidence interval [CI]: 55.5–64.7 months). The mean disease-free survival (DFS) was 55.4 months (95% CI: 49.6–61.1 months). The 1-year and 3-year overall survival rates were 96% and 86%, respectively. The 1-year and 3-year disease-free survival rates were 90% and 80%, respectively. Postoperative survival time decreased progressively with higher tumor stage.
Article Details
References
[2] Nakauchi M, Suda K, Nakamura K, et al. Laparoscopic subtotal gastrectomy for advanced gastric cancer: technical aspects and surgical, nutritional and oncological outcomes. Surg Endosc. Nov 2017;31(11):4631-4640. doi:10.1007/s00464-017- 5526-9
[3] Phạm Văn Nam. Nghiên cứu ứng dụng phẫu thuật nội soi cắt dạ dày, vét hạch D2, D2 mở rộng điều trị ung thư biểu mô dạ dày. Luận án tiến sĩ y học, Trường Đại Học Y Hà Nội; 2019.
[4] Kano Y, Ohashi M, Ida S, et al. Oncological feasibility of laparoscopic subtotal gastrectomy compared with laparoscopic proximal or total gastrectomy for cT1N0M0 gastric cancer in the upper gastric body. Gastric Cancer. Sep 2019;22(5):1060-1068. doi:10.1007/s10120-019-00947-7
[5] Lin JX, Huang CM, Zheng CH, al e. Surgical Outcomes of 2041 Consecutive Laparoscopic Gastrectomy Procedures for Gastric Cancer: A Large-Scale Case Control Study. PloS one. 2015;10(2)
[6] Chen K, Mou YP, Xu XW, al e. Short-term surgical and long-term survival outcomes after laparoscopic distal gastrectomy with D2 lymphadenectomy for gastric cancer. BMC Gastroenterol. 2014;14
[7] Kitano S, Shiraishi N, Uyama I, al e. A Multicenter Study on Oncologic Outcome of Laparoscopic Gastrectomy for Early Cancer in Japan. Ann Surg. 2007;245(1)
[8] Shinohara H, Kurahashi Y, Ishida Y. Gastric equivalent of the 'Holy Plane' to standardize the surgical concept of stomach cancer to mesogastric excision: updating Jamieson and Dobson's historic schema. Gastric Cancer. Mar 2021;24(2):273-282. doi:10.1007/s10120-020-01142-9